Dr. Carol K Chan, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1419 Foothill Blvd # 2, La Canada Flintridge, CA 91011 Phone: 818-790-0422 Fax: 818-790-0484 |
News Archive
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, presented results today of preclinical studies that demonstrate its orally-available targeted covalent drug candidate, AVL-192, achieves superior potency against drug-resistant mutations of the Hepatitis C Virus (HCV). These new data were presented today at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) international meeting in Boston, Massachusetts.
Tech Collective, Rhode Island's Bioscience and Information Technology industry association, today announces the launch of its 2014 Rhode Island Bioscience Awards.
If a new mother sustains an injury to her levator ani muscle-the main muscle supporting the pelvic floor-during vaginal childbirth, that woman is at risk of developing a pelvic floor disorder. Such an injury can have a substantial impact on a woman's quality of life.
Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.
By specially tagging the outer and inner membranes of red blood cells infected with the malaria parasite and tracking the cellular changes that precede the cell bursting event that disperses parasites to other blood cells, a group of researchers has deepened our understanding of how the malaria pathogen destroys the cells in which it resides.
› Verified 2 days ago